中华医学杂志（英文版）2022，Vol.135Issue(24)：2941-2949,9.DOI:10.1097/CM9.0000000000002508
Effect and safety of anaprazole in the treatment of duodenal ulcers:a randomized,rabeprazole-controlled,phase Ⅲ non-inferiority study
Effect and safety of anaprazole in the treatment of duodenal ulcers:a randomized,rabeprazole-controlled,phase Ⅲ non-inferiority study
Huiyun Zhu 1Qi Wang 2Yiqi Du 1Nonghua Lyu 3Zhaoshen Li 1Xue Pan 1Li Zhang 4Hongxin Sun 1Huizhen Fan 5Zhongwei Pan 6Caibin Huang 7Zhenwang Shi 8Jin Ding9
作者信息
- 1. Department of Gastroenterology,Changhai Hospital of Navy Military Medical University,Shanghai 200433,China
- 2. Department of Gastroenterology,Anqing Municipal Hospital,Anqing,Anhui 246004,China
- 3. Department of Gastroenterology,The First Affiliated Hospital of Nanchang University,Nanchang,Jiangxi 330006,China.
- 4. Drug Clinical Trial Institution,Changhai Hospital of Navy Military Medical University,Shanghai 200433,China
- 5. Department of Gastroenterology,Yichun People's Hospital,Yichun,Jiangxi 336028,China
- 6. Department of Gastroenterology,Meihekou Central Hospital,Meihekou,Jilin 135099,China
- 7. Department of Gastroenterology,The First Affiliated Hospital of Gannan Medical College,Ganzhou,Jiangxi 341001,China
- 8. Department of Gastroenterology,Hefei Second People's Hospital,Hefei,Anhui 230011,China
- 9. Department of Gastroenterology,Jinhua Central Hospital,Jinhua,Zhejiang 321099,China
- 折叠
摘要
关键词
Cytochrome P-450 CYP2C19/Non-inferiority trial/Peptic ulcer/Polymorphism/Genetic/Proton pump inhibitors/Anaprazole/RabeprazoleKey words
Cytochrome P-450 CYP2C19/Non-inferiority trial/Peptic ulcer/Polymorphism/Genetic/Proton pump inhibitors/Anaprazole/Rabeprazole引用本文复制引用
Huiyun Zhu,Qi Wang,Yiqi Du,Nonghua Lyu,Zhaoshen Li,Xue Pan,Li Zhang,Hongxin Sun,Huizhen Fan,Zhongwei Pan,Caibin Huang,Zhenwang Shi,Jin Ding..Effect and safety of anaprazole in the treatment of duodenal ulcers:a randomized,rabeprazole-controlled,phase Ⅲ non-inferiority study[J].中华医学杂志（英文版）,2022,135(24):2941-2949,9.
